Clinical Trials Logo

Invasive Pneumococcal Disease clinical trials

View clinical trials related to Invasive Pneumococcal Disease.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04464291 Completed - Acute Otitis Media Clinical Trials

An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years

SPECTRUM
Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Pneumococcal conjugate vaccine was added to the National Immunization Program in Russia in 2014 which could affect the changes in pneumococcal serotypes in growing population. The purpose of this study is to determine the spectrum of serotypes of S. pneumoniae in patients older 18-years: in healthy carriage, in patients with non-invasive and invasive forms of pneumococcal infection. The patients will be divide into several groups: 18-64-years old, 65 years old and older, immunocompromised patients, immunocompetent patients with concomitant diseases and patients from restricted organized collectives. This study is designed to meet the following objectives: To estimate the spectrum of serotypes of S. pneumoniae in adult population in different regions of Russia.

NCT ID: NCT01128439 Completed - Clinical trials for Invasive Pneumococcal Disease

Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease

Start date: July 2010
Phase:
Study type: Observational

This study will estimate the incidence of invasive pneumococcal disease in members of the Northern Kaiser Permanente healthcare system during each of the 5 following introduction of Prevnar 13.

NCT ID: NCT01083459 Completed - Clinical trials for Invasive Pneumococcal Disease

Impact of PCV on Disease and Colonization Among Native American Communities

Start date: January 2010
Phase: N/A
Study type: Observational

The purpose of this study is to determine the impact of pneumococcal conjugate vaccine on carriage of pneumococcus in the nasopharynx and on the incidence of invasive pneumococcal disease in the community.

NCT ID: NCT00853749 Completed - Clinical trials for Invasive Pneumococcal Disease

Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine

REPLAY
Start date: May 5, 2009
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to evaluate the immune response to 13-valent pneumococcal conjugate vaccine (13vPnCV) in children who as infants received either a complete series of PnCV versus a combination of PnCV and pneumococcal polysaccharide vaccine (PSV). This study is also intended to evaluate the safety of the 13vPnC.

NCT ID: NCT00371878 Completed - HIV Clinical Trials

Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection

Start date: February 2003
Phase: Phase 4
Study type: Interventional

Lung immune responses are regulated independently of systemic responses. Injected vaccines may induce optimal responses in blood but not at mucosal surfaces. We compared the responses in serum and lung fluid to injected pneumococcal conjugate vaccine.

NCT ID: NCT00227188 Completed - Clinical trials for Invasive Pneumococcal Disease

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

Start date: May 2003
Phase: N/A
Study type: Observational

The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population (children younger than 5 years)